Medical care quality in an advanced kidney disease clinic with multi-causal strategy
Abstract
Introduction: In stage IV chronic kidney disease (Stage-IV CKD), mortality and progression to extreme renal failure (ERF) are high. Objective: Assessing the quality of health care in an Advanced Kidney Disease Clinic (AKDC). Methods: Prospective study of patients with stage-IV CKD treated by a multidisciplinary formal team through an educational strategy, nutritional advice, clinical nephrology follow-up, aimed at achieving blood pressure goals (<130/80), proteinuria reduction, use of angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB), dyslipidemia treatment and preparation for dialysis. Results: 150 patients were analyzed, 50% were males, of 62.0 ± 14.4 years of age, 20.4% had vascular kidney diseases, 34.2% had diabetes and 62.5% had proteinuria with a Charlson index of 3.67 ± 1.57. In the 1.4-year follow-up (IQ: 0.6-2.4), there were decreases in the BP (147±35 to 132±28 mm), cholesterol (210±55 to 179±50 mg/dl) and LDL (129±52 to 108±37 mg/dl), and there was an increase in the use of ACEI/ARB (55.9 to 60.6%) and statins (32.2 to 63.3%). The mortality rate was 5.3 and the ERF rate was 14.5/100 patient-years. The glomerular function loss risk, which was higher than the median or ERF, increased with HTN, Pru >1 g/d and glomerular diseases, and had a 90% decrease with ACEI/ARB (p<0.001). At dialysis entry, hemoglobin levels of ≥10g%, hepatitis B vaccination and permanent access were more frequent than in the general population. Conclusions: Treatment goals were best achieved in a multidisciplinary clinic with a riskcontrol strategy, reducing progression risk factors and improving medical care upon dialysis entry.
References
González C, Schwedt E, Solá L, Ferreiro A, Mazzuchi N. Registro Uruguayo de Diálisis. Informe año 2005. Rev Nefrol Dial Traspl. 2009;29(3):94-100.
Mazzuchi Frantchez N, Schwedt Celiberti EC, González Bedat MC, Solá Schnir L, Garau Alvarez M, Caporale González N, et al. Evaluación del Programa de Diálisis para el Tratamiento de la Insuficiencia Renal Crónica en el Uruguay. Arch Med Interna (Montevideo). 2000;22(3, Supl.):S1-S72.
Solá L, González C, Schwedt E, Ferreiro A, Mazzuchi N. Prevención terciaria: condiciones de cuidado médico previo al ingreso a plan de diálisis crónica. Congreso de la Sociedad Latinoamericana de Nefrología e Hipertensión (13° : Punta del Este, Uruguay : 2004).
Lorenzo V, Martin M, Rufino M, Hernández D, Torres A, Ayus JC. Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: an observational cohort study. Am J Kidney Dis. 2004;43(6):999-1007.
Fernández-Cean J, Zampedri L, Altuna A, Pereyra M, García M, Matonte V, et al. Consulta muy tardía por insuficiencia renal crónica: riesgo muy alto para los pacientes y costo muy elevado para las instituciones de asistencia. Rev Méd Uruguay. 2005;21(3):231-5.
Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41(1):1-12.
Schoolwerth AC, Engelgau MM, Rufo KH, Vinicor F, Hostetter TH, Chianchiano D, et al. Chronic Kidney Disease: A Public Health Problem That Needs a Public Health Action Plan. Prev Chronic Dis. 2006;3(2):A57.
Wauters JP, Lameire N, Davison A, Ritz E. Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement. Nephrol Dial Transplant. 2005;20(3):490-6.
Arora P, Obrador GT, Ruthazer R, Kausz AT, Meyer KB, Jenuleson CS, et al. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol. 1999;10(6):1281-6.
Navaneethan SD, Aloudat S, Singh S. A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. BMC Nephrol. 2008;9:3.
Goldstein M, Yassa T, Dacouris N, McFarlane P. Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis. 2004;44(4):706-14.
Curtis BM, Ravani P, Malberti F, Kennett F, Taylor PA, Djurdjev O, et al. The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant. 2005;20(1):147-54.
Ruggenenti P, Perticucci E, Cravedi P, Gambara V, Costantini M, Sharma SK, et al. Role of remission clinics in the longitudinal treatment of
CKD. J Am Soc Nephrol. 2008;19(6):1213-24.
Ruggenenti P, Perticucci E, Cravedi P, Gambara V, Costantini M, Sharma SK, et al. Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol. 2008;19(6):1213-24.
Alcázar Arroyo R, Orte Martínez L, Otero González A. Enfermedad renal crónica avanzada. Nefrologia (Madr.) 2008;28(Supl. 3):3-6.
Curtis BM, Barrett BJ, Djurdjev O, Singer J, Levin A. Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada. Am J Kidney Dis. 2007;50(5):733-42.
Mazzuchi N, Schwedt E, Solá L, González C, Ferreiro A. Risk factors and prevention of end stage renal disease in Uruguay. Ren Fail. 2006;28(8):617-25.
Solá L, Ríos P, Mazzuchi N, Schwedt M. National Renal Healthcare Program in Uruguay Prevention and Early Detection of Renal Disease [Internet]. Disponible en: http://www.nefrouruguay.com [Consulta: ago. 2013].
Schwedt E, Solá L, Ríos P, Mazzuchi N. Guía clínica para identificación, evaluación y manejo del paciente con enfermedad renal crónica en el primer nivel de atención. Programa de Salud Renal [Internet]. Montevideo: Fondo Nacional de Recursos, Ministerio de Salud Pública, 2006. (Publicación Técnica; 2). Disponible en: http://www.fnr.gub.uy/sites/default/files/publicaciones/FNR_guia_renal_cronica.pdf [Consulta: ago. 2013].
Lee W, Campoy S, Smits G, Vu Tran Z, Chonchol M. Effectiveness of a chronic kidney disease clinic in achieving K/DOQI guideline targets at initiation of dialysis--a single-centre experience. Nephrol Dial Transplant. 2007;22(3):833-8.
Verdalles U, García de Vinuesa S, Goicoechea M, Gómez Campderá F, Luño J. Evaluación del cumplimiento de las guías terapéuticas en la práctica clínica en pacientes con enfermedad renal crónica (ERC). Nefrologia (Madr.) 2007;27(3):320-8.
Taskapan H, Tam P, Au V, Chow S, Fung J, Nagai G, et al. Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic. Int Urol Nephrol. 2008;40(3):841-8.
Thanamayooran S, Rose C, Hirsch DJ. Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets. Nephrol Dial Transplant. 2005;20(11):2385-93.
García de Vinuesa S. Factores de progresión de la enfermedad renal crónica. Prevención secundaria. Nefrología (Madr.) 2008; 28(Supl. 3):17-21.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-305.
National Kidney Foundation's KIdney Early Evaluation Program (KEEP) Annual Data Report 2011. Am J Kidney Dis. 2012;59(3, Suppl. 2):S1-S174.
Zhang AH, Tam P, LeBlanc D, Zhong H, Chan CT, Bargman JM, et al. Natural history of CKD stage 4 and 5 patients following referral to renal management clinic. Int Urol Nephrol. 2009;41(4):977-82.
Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet. 2001;357(9268):1601-8.
Gansevoort RT, Sluiter WJ, Hemmelder MH, de Zeeuw D, de Jong PE. Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant. 1995;10(11):1963-74.
Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135(2):73-87.
Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, et al. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int. 2001;60(3):1131-40.
Hebert LA, Bain RP, Verme D, Cattran D, Whittier FC, Tolchin N, et al. Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group. Kidney Int. 1994;46(6):1688-93.
Chiurchiu C, Remuzzi G, Ruggenenti P. Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analyses. J Am Soc Nephrol. 2005;16(Suppl 1):S58-63.
Stevens LA, Greene T, Levey AS. Surrogate end points for clinical trials of kidney disease progression. Clin J Am Soc Nephrol. 2006;1(4):874-84.
Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008;372(9638):547-53.
Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis. 2008;52(4):661-71.
Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int. 2003;63(2):738-43.
Barril G, Teruel JL. Calendario de vacunas en la enfermedad renal crónica avanzada. Nefrologia (Madr.) 2008;28(Supl. 3):1-139.
Obi Y, Kimura T, Nagasawa Y, Yamamoto R, Yasuda K, Sasaki K, et al. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin J Am Soc Nephrol. 2010;5(9):1558-65.
Mendelssohn DC, Curtis B, Yeates K, Langlois S, MacRae JM, Semeniuk LM, et al. Suboptimal initiation of dialysis with and without early referral to a nephrologist. Nephrol Dial Transplant. 2011;26(9):2959-65.
Estados Unidos. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney, Urologic and Hematologic Diseases. Atlas of Chronic Kidney Disease in the United States. USRDS Annual Data Report 2012 [Internet]. Disponible en: https://www.usrds.org/2012/pdf/v1_00intro_12.pdf (consulta: marzo 2013).
